The main aim of WP1 will be to identify and characterize novel anti-biofilm leads to be used on the printed devices and formulations that will be developed in WP2. The desired compound features for active leads will include: i) microbicidal activity and/or ii) prevention of biofilm formation. The starting collection will include known anti- biofilms that are currently being investigated such as Quorum Sensing Inhibitors (QSI) and Antimicrobial Peptides (AMP).
WP1: Identification and characterization of anti-biofilm leads
- PRINT-AID at EUROPEAN RESEARCHERS’ NIGHT 2016 2017-01-20 13:32:15
- PRINT-AID KICKED-OFF Jan 18th-19th 2017 2017-01-20 08:41:00
- 2.3 MILLION EUROS TO DEVELOP 3D PRINTING OF ANTI-INFECTIVE MEDICAL DEVICES 2016-05-10 08:41:00
- PRINT-AID publications to appear soon 2017-02-03 08:41:00